Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07148232 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness

StatusRecruiting
PhasePhase 4
Started2025-11-14
View on ClinicalTrials.gov ↗

Amendment history

2025-11-19
Study Identification, Study Status v4
Re-verified, no change to tracked fields
2025-11-14
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v3
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2025-10-31→confirmed 2025-11-14
Study sitesdetails revised at 1 of 1 site
2025-09-23
Study Identification, Study Status v2
Study title+16 characters
Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness
2025-09-03
Study Identification, Study Status, Study Description, Study Design, Arms and Interventions v1
PhasePhase 1/2→Phase 4
Study description+96 characters
[...] will be randomized to one of two groups: Intervention group: receives tobacco treatment with 6 month supply of NRT and coaching for 6 months of pharmacist consultation, monthly delivery of nicotine replacement therapy, and telephone wellness coaching. Control group: receives tobaccopharmacist treatmentconsultation withand monthly delivery of nicotine replacement therapy for 3 month supply of NRTmonths. Participants will be follow-followed up at 1, 3 and 6 months.
2025-08-22
Original filing
This study is investigating tobacco use and providing tobacco treatment among people experiencing homelessness in California, in San Francisco and Los Angeles.
Trial Details
NCT Number NCT07148232
Lead Sponsor University of California, San Francisco
Collaborators: Tobacco Related Disease Research Program
Conditions Tobacco Cessation, Tobacco Abstinence, Tobacco Use, Tobacco Use Cessation, Tobacco Dependence
Enrollment 150 participants
Start Date 2025-11-14
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-21